This is a preview of subscription content, log in via an institution to check access.
Notes
2018 US dollars
Reference
Lin JK, et al. Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma. Journal of Clinical Oncology : 3 Jun 2019. Available from: URL: http://doi.org/10.1200/JCO.18.02079
Rights and permissions
About this article
Cite this article
CAR-T cell therapies cost effective in diffuse large B-cell lymphoma?. PharmacoEcon Outcomes News 830, 7 (2019). https://doi.org/10.1007/s40274-019-5958-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5958-7